87 related articles for article (PubMed ID: 18343746)
21. A case of refractory chronic respiratory tract infection due to Pseudomonas aeruginosa successfully controlled by combination of clarithromycin and azithromycin.
Yamamoto Y; Izumikawa K; Hosogaya N; Morinaga Y; Nakamura S; Imamura Y; Miyazaki T; Sakamoto N; Ishimatu Y; Kakeya H; Yanagihara K; Yasuoka A; Kohno S
Intern Med; 2012; 51(11):1383-6. PubMed ID: 22687847
[TBL] [Abstract][Full Text] [Related]
22. Reverse kinetics of angiopoietin-2 and endotoxins in acute pyelonephritis: Implications for anti-inflammatory treatment?
Safioleas K; Giamarellos-Bourboulis EJ; Carrer DP; Pistiki A; Sabracos L; Deliveliotis C; Chrisofos M
Cytokine; 2016 May; 81():28-34. PubMed ID: 26844659
[TBL] [Abstract][Full Text] [Related]
23. Monobactam and aminoglycoside combination therapy against metallo-beta-lactamase-producing multidrug-resistant Pseudomonas aeruginosa screened using a 'break-point checkerboard plate'.
Araoka H; Baba M; Takagi S; Matsuno N; Ishiwata K; Nakano N; Tsuji M; Yamamoto H; Seo S; Asano-Mori Y; Uchida N; Masuoka K; Wake A; Taniguchi S; Yoneyama A
Scand J Infect Dis; 2010 Mar; 42(3):231-3. PubMed ID: 20001223
[TBL] [Abstract][Full Text] [Related]
24. Effect of clarithromycin in patients with suspected Gram-negative sepsis: results of a randomized controlled trial.
Giamarellos-Bourboulis EJ; Mylona V; Antonopoulou A; Tsangaris I; Koutelidakis I; Marioli A; Raftogiannis M; Kopterides P; Lymberopoulou K; Mouktaroudi M; Papageorgiou C; Papaziogas B; Georgopoulou AP; Tsaganos T; Papadomichelakis E; Gogos C; Ladas M; Savva A; Pelekanou A; Baziaka F; Koutoukas P; Kanni T; Spyridaki A; Maniatis N; Pelekanos N; Kotsaki A; Vaki I; Douzinas EE; Koratzanis G; Armaganidis A
J Antimicrob Chemother; 2014 Apr; 69(4):1111-8. PubMed ID: 24292991
[TBL] [Abstract][Full Text] [Related]
25. Experimental Pseudomonas aeruginosa sepsis: absence of synergy between ticarcillin and tobramycin.
Chusid MJ; Davis SD; Sarff LD
J Lab Clin Med; 1983 Mar; 101(3):441-9. PubMed ID: 6402553
[TBL] [Abstract][Full Text] [Related]
26. S-thanatin in vitro prevents colistin resistance and improves its efficacy in an animal model of Pseudomonas aeruginosa sepsis.
Cirioni O; Wu G; Li L; Orlando F; Silvestri C; Ghiselli R; Shen Z; Gabrielli E; Brescini L; Lezoche G; Provinciali M; Guerrieri M; Giacometti A
Peptides; 2011 Apr; 32(4):697-701. PubMed ID: 21262298
[TBL] [Abstract][Full Text] [Related]
27. Pre-treatment with probiotics prolongs survival after experimental infection by multidrug-resistant Pseudomonas aeruginosa in rodents: an effect on sepsis-induced immunosuppression.
Machairas N; Pistiki A; Droggiti DI; Georgitsi M; Pelekanos N; Damoraki G; Kouraklis G; Giamarellos-Bourboulis EJ
Int J Antimicrob Agents; 2015 Apr; 45(4):376-84. PubMed ID: 25601531
[TBL] [Abstract][Full Text] [Related]
28. Immunomodulatory therapies for sepsis: unexpected effects with macrolides.
Giamarellos-Bourboulis EJ
Int J Antimicrob Agents; 2008 Nov; 32 Suppl 1():S39-43. PubMed ID: 18707849
[TBL] [Abstract][Full Text] [Related]
29. In vivo challenging of polymyxins and levofloxacin eye drop against multidrug-resistant Pseudomonas aeruginosa keratitis.
Tajima K; Miyake T; Koike N; Hattori T; Kumakura S; Yamaguchi T; Matsumoto T; Fujita K; Kuroda M; Ito N; Goto H
J Infect Chemother; 2014 Jun; 20(6):343-9. PubMed ID: 24726376
[TBL] [Abstract][Full Text] [Related]
30. Oral administration of Bifidobacterium longum prevents gut-derived Pseudomonas aeruginosa sepsis in mice.
Matsumoto T; Ishikawa H; Tateda K; Yaeshima T; Ishibashi N; Yamaguchi K
J Appl Microbiol; 2008 Mar; 104(3):672-80. PubMed ID: 17927741
[TBL] [Abstract][Full Text] [Related]
31. [Proteomic study of peripheral blood lymphocytes of rabbits with severe burn and Pseudomonas aeruginosa sepsis].
Zeng JZ; Zhang PH; Li LL; Ren LC; Liang PF; Huang XY
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2009 Aug; 21(8):455-9. PubMed ID: 19695163
[TBL] [Abstract][Full Text] [Related]
32. Efficacy of tachyplesin III, colistin, and imipenem against a multiresistant Pseudomonas aeruginosa strain.
Cirioni O; Ghiselli R; Silvestri C; Kamysz W; Orlando F; Mocchegiani F; Di Matteo F; Riva A; Lukasiak J; Scalise G; Saba V; Giacometti A
Antimicrob Agents Chemother; 2007 Jun; 51(6):2005-10. PubMed ID: 17403995
[TBL] [Abstract][Full Text] [Related]
33. Immunomodulatory intervention with interferon-γ in Escherichia coli pyelonephritis.
Katsaris MP; Adamis T; Pistiki A; Carrer DP; Galani I; Sabracos L; Droggiti DI; Georgitsi M; Damoraki G; Giamarellos-Bourboulis EJ; Chrisofos M
J Urol; 2014 Aug; 192(2):600-6. PubMed ID: 24681329
[TBL] [Abstract][Full Text] [Related]
34. Colistin serum concentrations after intravenous administration in critically ill patients with serious multidrug-resistant, gram-negative bacilli infections: a prospective, open-label, uncontrolled study.
Markou N; Markantonis SL; Dimitrakis E; Panidis D; Boutzouka E; Karatzas S; Rafailidis P; Apostolakos H; Baltopoulos G
Clin Ther; 2008 Jan; 30(1):143-51. PubMed ID: 18343250
[TBL] [Abstract][Full Text] [Related]
35. Treatment of multidrug-resistant pseudomonas aeruginosa using extended-infusion antimicrobial regimens.
Heil EL; Lowery AV; Thom KA; Nicolau DP
Pharmacotherapy; 2015 Jan; 35(1):54-8. PubMed ID: 25556715
[TBL] [Abstract][Full Text] [Related]
36. Efficacy and safety of colistin (colistimethate sodium) for therapy of infections caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii in Siriraj Hospital, Bangkok, Thailand.
Koomanachai P; Tiengrim S; Kiratisin P; Thamlikitkul V
Int J Infect Dis; 2007 Sep; 11(5):402-6. PubMed ID: 17291803
[TBL] [Abstract][Full Text] [Related]
37. Continuous administration of PBP-2- and PBP-3-specific beta-lactams causes higher cytokine responses in murine Pseudomonas aeruginosa and Escherichia coli sepsis.
Buijs J; Dofferhoff AS; Mouton JW; van der Meer JW
J Antimicrob Chemother; 2007 May; 59(5):926-33. PubMed ID: 17395686
[TBL] [Abstract][Full Text] [Related]
38. Paradoxical synergistic effects of tumour necrosis factor and interleukin 1 in murine gut-derived sepsis with Pseudomonas aeruginosa.
Matsumoto T; Tateda K; Miyazaki S; Furuya N; Ohno A; Ishii Y; Hirakata Y; Yamaguchi K
Cytokine; 1999 May; 11(5):366-72. PubMed ID: 10328876
[TBL] [Abstract][Full Text] [Related]
39. Antimicrobial-induced endotoxaemia in patients with sepsis in the field of acute pyelonephritis.
Giamarellos-Bourboulis EJ; Perdios J; Gargalianos P; Kosmidis J; Giamarellou H
J Postgrad Med; 2003; 49(2):118-22. PubMed ID: 12867685
[TBL] [Abstract][Full Text] [Related]
40. Aerosolized amikacin and oral clarithromycin to eradicate Mycobacterium abscessus in a patient with cystic fibrosis: an 8-year follow-up.
Colin AA; Ali-Dinar T
Pediatr Pulmonol; 2010 Jun; 45(6):626-7. PubMed ID: 20503290
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
